Bradley L Campbell Amicus Therapeutics, Inc. (FOLD) insider trading activity

Bradley L Campbell is President and CEO of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 886,654 shares of FOLD, which is worth approximately $8.88 Million. The most recent transaction as insider was on Jul 01, 2024, when has been sold 1,400 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $14,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 887K

0% 3M change

8.77% 12M change

Total Value Held $8.88 Million

Bradley L Campbell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2024	SELL Open market or private sale	$14,000 $10.0 p/Share	1,400 Reduced 0.16%	886,654 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$12,054 $8.61 p/Share	1,400 Added 0.16%	888,054 Common Stock
Jun 03 2024	SELL Open market or private sale	$75,000 $10.0 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
May 01 2024	SELL Open market or private sale	$75,525 $10.07 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Apr 01 2024	SELL Open market or private sale	$87,525 $11.67 p/Share	7,500 Reduced 0.84%	886,654 Common Stock

Apr 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$153,545 $11.48 p/Share	13,375 Reduced 1.49%	886,654 Common Stock
Mar 01 2024	SELL Open market or private sale	$208,045 $13.14 p/Share	15,833 Reduced 1.78%	871,219 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$165,454 $10.45 p/Share	15,833 Added 1.75%	887,052 Common Stock
Feb 15 2024	SELL Open market or private sale	$58,338 $14.0 p/Share	4,167 Reduced 0.48%	871,219 Common Stock
Feb 01 2024	SELL Open market or private sale	$198,862 $12.56 p/Share	15,833 Reduced 1.78%	875,386 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	$165,454 $10.45 p/Share	15,833 Added 1.75%	891,219 Common Stock
Jan 09 2024	SELL Payment of exercise price or tax liability	$321,826 $13.65 p/Share	23,577 Reduced 2.62%	875,386 Common Stock
Jan 04 2024	SELL Payment of exercise price or tax liability	$99,025 $13.44 p/Share	7,368 Reduced 0.81%	898,963 Common Stock
Jan 03 2024	SELL Payment of exercise price or tax liability	$561,143 $13.53 p/Share	41,474 Reduced 4.38%	906,331 Common Stock
Jan 02 2024	SELL Payment of exercise price or tax liability	$220,036 $14.24 p/Share	15,452 Reduced 1.6%	947,805 Common Stock
Jan 02 2024	SELL Open market or private sale	$225,461 $14.24 p/Share	15,833 Reduced 1.64%	947,805 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	153,810 Added 13.77%	963,257 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$165,454 $10.45 p/Share	15,833 Added 1.63%	956,138 Common Stock
Dec 18 2023	BUY Grant, award, or other acquisition	-	17,286 Added 2.09%	809,447 Common Stock
Dec 01 2023	SELL Open market or private sale	$129,658 $11.08 p/Share	11,702 Reduced 1.46%	792,161 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	$34,403 $2.94 p/Share	11,702 Added 1.43%	803,863 Common Stock
Nov 01 2023	SELL Open market or private sale	$128,349 $10.97 p/Share	11,700 Reduced 1.46%	792,161 Common Stock

BLC

Bradley L Campbell

President and CEO

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account